Certican 0.75mg Tablet

₨ 30,142

In stock
FormulaEverolimus (0.75mg)
Pack size60's
FormTablet
Therapeutic useTransplant rejection prevention and some cancers, including kidney, breast and neuroendocrine cancers
1 other brand with the same formulaCompare
Delivery in 2 to 3 working daysTo cities across Pakistan, delivery from ₨ 300
Cash on deliveryOr pay by bank transfer or card at checkout
Genuine productsFrom a DRAP-licensed pharmacy
Damaged or wrong item?We take it back. Read the return policy
Have a prescription? Upload it and our pharmacist will check your order.Questions about this product? WhatsApp 0336 3300001

About this product

Overview

Certican 0.75mg Tablet contains the active ingredient Everolimus and is prescribed for various medical conditions, including organ transplantation and certain types of cancer. Everolimus belongs to a class of medications known as mammalian target of rapamycin (mTOR) inhibitors, which work by inhibiting the mTOR pathway involved in cell growth and proliferation.

Uses

Certican 0.75mg Tablet is primarily used as an immunosuppressant medication to prevent organ rejection in individuals who have undergone kidney, liver, or heart transplantation. It is also prescribed for the treatment of certain types of advanced or metastatic cancers, including renal cell carcinoma, breast cancer, neuroendocrine tumors, and pancreatic neuroendocrine tumors.

Administration

Certican 0.75mg Tablet is taken orally, usually once daily, with or without food, as directed by a healthcare professional. The dosage may vary depending on the patient’s medical condition, response to treatment, and other medications they may be taking. It is important to follow the prescribed dosage regimen and not to adjust the dose without consulting a healthcare provider.

Side Effects

Common side effects associated with Certican 0.75mg Tablet may include diarrhea, nausea, vomiting, loss of appetite, fatigue, headache, and mouth sores. Some individuals may experience more severe side effects such as infections, anemia, thrombocytopenia, hyperglycemia, and changes in kidney function. Rarely, Certican may increase the risk of developing certain types of cancer, including skin cancer and lymphoma.

Precautions

Before starting Certican 0.75mg Tablet, patients should inform their healthcare provider of any medical conditions they have, especially if they have a history of liver or kidney problems, diabetes, or high cholesterol. Everolimus may interact with other medications, so it is important to disclose all current medications, including over-the-counter drugs and supplements. Patients should avoid grapefruit and grapefruit juice while taking Certican, as it may increase the levels of everolimus in the blood.

visit to khasmart.pk 100% orignal products delivery within 2 to 3 working days Across Pakistan

This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.

Other brands of Everolimus

These medicines also contain Everolimus, but in a different strength or pack. Do not switch to a different strength without asking your doctor.

MedicineManufacturerStrengthPrice
Certican 0.25mg TabletNovartis Pharma0.25mgRs 16,740

See all brands and prices on our Everolimus page.

Customer reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “Certican 0.75mg Tablet”